Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.785 EUR | +0.28% | +3.18% | +59.95% |
Apr. 16 | Finland’s Nightingale Health Plots US Expansion | MT |
Apr. 16 | Nightingale Health to Establish A Laboratory in the United States | CI |
Sales 2024 * | 4.7M 5.08M | Sales 2025 * | 8.7M 9.4M | Capitalization | 108M 116M |
---|---|---|---|---|---|
Net income 2024 * | -16M -17.28M | Net income 2025 * | -16M -17.28M | EV / Sales 2024 * | 8.9 x |
Net cash position 2024 * | 65.9M 71.17M | Net cash position 2025 * | 52.2M 56.38M | EV / Sales 2025 * | 6.38 x |
P/E ratio 2024 * |
-6.61
x | P/E ratio 2025 * |
-6.61
x | Employees | 81 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.93% |
Latest transcript on Nightingale Health Oyj
1 day | +0.28% | ||
1 week | +3.18% | ||
Current month | +3.18% | ||
1 month | -6.05% | ||
3 months | +75.69% | ||
6 months | +58.24% | ||
Current year | +59.95% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Würtz
FOU | Founder | - | 01-12-31 |
Satu Saksman
FOU | Founder | 48 | 01-12-31 |
Pasi Soininen
FOU | Founder | - | 01-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-12-16 | |
Chairman | 61 | 20-12-31 | |
Olli Pekka Karhi
BRD | Director/Board Member | 61 | 14-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 1.785 | +0.28% | 23,258 |
24-06-06 | 1.78 | +7.55% | 63,685 |
24-06-05 | 1.655 | -2.36% | 49,171 |
24-06-04 | 1.695 | -3.42% | 39,361 |
24-06-03 | 1.755 | +1.45% | 23,716 |
Delayed Quote Nasdaq Helsinki, June 07, 2024 at 11:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.95% | 116M | |
-4.87% | 29.6B | |
+31.35% | 8.65B | |
+34.03% | 4.42B | |
-28.91% | 2.69B | |
-9.91% | 1.6B | |
-21.02% | 1.36B | |
-35.78% | 1.1B | |
+3.28% | 924M | |
-43.36% | 791M |
- Stock Market
- Equities
- HEALTH Stock